In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
about
Current status and patent prospective of animal models in diabetic researchLeptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic MiceEffect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin.Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.Microfluidic perfusion systems for secretion fingerprint analysis of pancreatic islets: applications, challenges and opportunities.Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity modelBLT2 expression improves skin integrity and protects from alterations caused by hyperglycemia in type 2 diabetes.Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.
P2860
Q26799371-D353ABC1-5BAD-4E3C-AA86-96B59A1F9678Q33846858-F2D6FA8C-C41E-4662-BB0C-53A7A55B24DFQ34279229-2C5D6817-5057-4748-B301-010EE925ABE3Q36467779-FD5CB5A8-E8F1-4148-948A-719400BACA68Q37728252-41117EDB-2262-4E53-B196-9521C0B7ED8CQ38193387-7D3E4D5D-AF43-4ADD-9091-86E5A3F85C8CQ38687419-59030D3E-5AE0-4F0A-AA4B-6C6858B357E8Q39000515-6B3C4A23-2AB8-4F7C-841D-87C01815B862Q42292389-1599D501-0B8B-429E-88D8-32B98D972A8DQ50320378-E5C53CF6-E189-4A0B-8C53-8CA6855FEC65
P2860
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@ast
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@en
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@nl
type
label
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@ast
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@en
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@nl
prefLabel
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@ast
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@en
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@nl
P2860
P1476
In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.
@en
P2093
P2860
P356
10.1046/J.1463-1326.1999.00014.X
P577
1999-03-01T00:00:00Z